Advanced search
Publication Cover
Hypertension in Pregnancy Volume 30, 2011 - Issue 2
Submit an article Journal homepage
93
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Elevated Serum-Soluble Fas in Preeclampsia: Correlation with Clinical, Laboratory, and Doppler Parameters

Walid El-Sherbiny Department of Obstetrics and Gynecology, Cairo University, Cairo, EgyptCorrespondence[email protected]
, MD,
Aml Soliman Department of Clinical and Chemical Pathology, Cairo University, Cairo, Egypt
, MD &
Akmal El-Mazny Department of Obstetrics and Gynecology, Cairo University, Cairo, Egypt
, MD
Pages 221-230 | Published online: 20 Jan 2011

REFERENCES

  • Myers JE, Baker PN. Hypertensive diseases and eclampsia. Curr Opin Obstet Gynecol 2002; 14:119–125.
  • Chen Q, Jones D, Stone P, Ching LM, Chamley L. C enhances phagocytosis of necrotic trophoblasts by endothelial cells and protects the phagocytosing endothelial cells from activation. Placenta 2009; 30:163–168.
  • Redman CW, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response – A review. Placenta 2003; 24(Suppl.):21–27.
  • Cleveland JL, Ihle JN. The Fas and the cytoplasmic apoptosis. Cell 1995; 81:479–483.
  • Nagata S, Goldstein P. The Fas death factor. Science 1995; 267:1449–1456.
  • von Dadelszen P, Watson RW, Noorwali F, Maternal neutrophil apoptosis in normal pregnancy, preeclampsia, and normotensive intrauterine growth restriction. Am J Obstet Gynecol 1999; 181:408–414.
  • Ishihara E, Matsuo H, Murakoshi H. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either pre-eclampsia or intrauterine growth retardation. Obst Gynecol. 1999; 181:408–414.
  • ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. No. 33, January 2002 American College of Obstetricians and Gynecologists. Obstet Gynecol 2002; 99:159–167.
  • Pesce A, First M. Proteinurea – An integrated review. In: Cameron JS, et al. eds. Kidney Disease. Vol. 1, 1st ed., New York: Marcel Dekker, 1979:247–249.
  • Arias F. Accuracy of the middle-cerebral-to-umbilical-artery resistance index ratio in the prediction of neonatal outcome in patients at high risk for fetal and neonatal complications. Am J Obstet Gynecol 1994; 171:1541–1545.
  • Rathmell JC, Thompson CB. The central effectors of cell death in the immune system. Annu Rev Immunol 1999; 17:781–828.
  • Peter M, Scaffidi JM. The death receptors. Results Probl Cell Differ. 1999; 23:25–63.
  • Protonotariou E, Rizos D, Malamitsi-Puchner A, Sarandakou A, Botsis D. Tissue polypeptide specific antigen and soluble Fas during normal pregnancy and early life. In Vivo 2006; 20:901–905.
  • Norwitz ER, Hsu CD, Repke JT. Acute complications of preeclampsia. Clin Obstet Gynecol 2002; 45:308–329.
  • Wang W, Tzanidis A, Divjak M, Thomson NM, Stein-Oakley AN. Altered signaling and regulatory mechanisms of apoptosis in focal and segmental glomerulosclerosis. J Am Soc Nephrol 2001; 12:1422–1433.
  • Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270:1189–1192.
  • Hsu C, Hairab H, Serum Soluble BF. Fas levels in precclampsia. Obstet Gynecol 2002; 186:158–166.
  • Sziller I, Hupuczi P, Normand N, Fas (TNFRSF6) gene polymorphism in pregnant women with hemolysis, elevated liver enzymes, and low platelets and in their neonates. Obstet Gynecol 2006; 107:582–587.
  • Laskowska M, Laskowska K, Leszczynska-Gorzelak B, Oleszczuk J. Evaluation of the maternal and umbilical vein serum sFas/sFasL system in pregnancies complicated by pre-eclampsia with intrauterine growth retardation. Eur J Obstet Gynecol Reprod Biol 2005; 15:275–281.
  • Aysun U, Gfluiliz G, Melek E, Ilhan T. Expression of Fas, Bcl-2 and p53 molecules in glomerulonephritis and their correlations with clinical and laboratory findings. Nephrology 2005; 10:311–316.
  • Hoshimoto K, Hayashi M, Ohkura T. Plasma levels of soluble Fas during normal pregnancy. Gynecol Obstet Invest 2001; 51:96–98.
  • Sato M, Knuma T. Fas-ligand system in the peripheral blood of patients with renal disease. Nephron 2000; 85:107–113.
  • Cosson E, Bringuier F, Paries J, Ligand pathway is impaired in patients with type 2 diabetes. Influence of hypertension and insulin resistance. Diabetes Metab 2005; 31:47–54.
  • Baschat AA, Gembruch U. The cerebroplacental Doppler ratio revisited. Ultrasound Obstet Gynecol 2003; 21:124–127.
  • Jain M, Farooq T, Shukla RC. Doppler cerebroplacental ratio for the prediction of adverse perinatal outcome. Int J Gynaecol Obstet 2004; 86:384–385.
  • To WW, Chan AM, Mok KM. Use of umbilical-cerebral Doppler ratios in predicting fetal growth restriction in near-term fetuses. Aust NZJ Obstet Gynaecol 2005; 45:130–136.
  • Hoffman C, Galan HL. Assessing the “at-risk” fetus: Doppler ultrasound. Curr Opin Obstet Gynecol 2009; 21:161–166.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.